Color Genomics Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 50
Employees
  • Latest Deal Type
  • Seed
  • Investors
  • 57

Color Genomics General Information

Description

Developer of genetic testing kits designed to be used for hereditary health issues. The company's kits include a device to provide a saliva sample that is sent back in a postage-paid package where it is analyzed and lists a record of hereditary disorders along with personalized screening guidelines, enabling users to take control of their health and create a personalized healthcare plan anytime.

Contact Information

Website
Formerly Known As
Color Global
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Other Healthcare Services
Primary Office
  • 831 Mitten Road
  • Suite 100
  • Burlingame, CA 94010
  • United States
+1 (844) 000-0000

Color Genomics Timeline

2017201820192020
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Color Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Seed Round 00000 Completed Generating Revenue
7. Secondary Transaction - Private 00000 Completed Generating Revenue
6. Later Stage VC (Series D) 15-Jan-2020 0000 00000 Completed Generating Revenue
5. Grant 21-Aug-2019 00.00 00000 Completed Generating Revenue
4. Later Stage VC (Series C1) 17-Jul-2017 000.00 00000 00000 Completed Generating Revenue
3. Early Stage VC (Series B) 27-Sep-2016 0000 00000 00000 Completed Generating Revenue
2. Early Stage VC (Series A) 15-May-2015 $15M $56M 0000 Completed Generating Revenue
1. Early Stage VC 01-Mar-2011 $41M $41M Completed Generating Revenue
To view Color Genomics’s complete valuation and funding history, request access »

Color Genomics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series C 0,000,000 00.000000 00.00 000.00 000.00 00 000.00 00.000
Series B 7,790,000 $0.000100 $0.39 $6.44 $6.44 1x $6.44 23.24%
Series A 6,536,934 $0.000100 $0.21 $3.46 $3.46 1x $3.46 19.5%
To view Color Genomics’s complete cap table history, request access »

Color Genomics Executive Team (9)

Name Title Board Seat Contact Info
Othman Laraki Co-founder, Chief Executive Officer & Board Member
Wendy McKennon Head, Product and Design
You’re viewing 2 of 9 executive team members. Get the full list »

Color Genomics Board Members (4)

Name Representing Role Since
Elad Gil Ph.D Color Genomics Co-Founder & Chairman 000 0000
Hemant Taneja General Catalyst Board Member 000 0000
Othman Laraki Color Genomics Co-founder, Chief Executive Officer & Board Member 000 0000
Susan Wagner Self Board Member 000 0000
To view Color Genomics’s complete board members history, request access »

Color Genomics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Color Genomics Investors (57)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
SciFi VC Venture Capital Minority 000 0000 000000 0
The Strand Partners PE/Buyout Minority 000 0000 000000 0
T. Rowe Price Asset Manager Minority 000 0000 000000 0
Viking Global Investors Hedge Fund Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
You’re viewing 5 of 57 investors. Get the full list »